In recent years， C. albicans and C. glabrata have been identified as the main cause of candidemia and invasive candidiasis in hospitalized and immunocompromised patients. In order to colonize the human host， these fungi express several virulence factors such as the response to oxidative stress and the formation of biofilms. In the expression of these virulence factors， the cell wall of C. albicans and C. glabrata is of fundamental importance. As the outermost structure of the yeast， the cell wall is the first to come in contact with the reactive oxygen species (ROS) generated during the respiratory outbreak， and in the formation of biofilms， it is the first to adhere to organs or medical devices imp... More
In recent years， C. albicans and C. glabrata have been identified as the main cause of candidemia and invasive candidiasis in hospitalized and immunocompromised patients. In order to colonize the human host， these fungi express several virulence factors such as the response to oxidative stress and the formation of biofilms. In the expression of these virulence factors， the cell wall of C. albicans and C. glabrata is of fundamental importance. As the outermost structure of the yeast， the cell wall is the first to come in contact with the reactive oxygen species (ROS) generated during the respiratory outbreak， and in the formation of biofilms， it is the first to adhere to organs or medical devices implanted in the human host. In both processes， several cell wall proteins (CWP) are required， since they promote attachment to human cells or abiotic surfaces， as well as to detoxify ROS. In our working group we have identified moonlighting CWP in response to oxidative stress as well as in the formation of biofilms. Having identified moonlighting CWP in Candida species in response to two virulence factors indicates that these proteins may possibly be immunodominant. The aim of the present work was to evaluate whether proteins of this type such as fructose-bisphosphate aldolase (Fba1)， phosphoglycerate kinase (Pgk) and pyruvate kinase (Pk)， could confer protection in a mouse model against C. albicans and C. glabrata. For this， recombinant proteins His-Fba1， His-Pgk and His-Pk were constructed and used to immunize several groups of mice. The immunized mice were infected with C. albicans or C. glabrata， and subsequently the liver， spleen and kidney were extracted and the number of CFU was determined. Our results showed that Pk confers immunity to mice against C. albicans， while Fba1 to C. glabrata. This data allows us to conclude that the moonlighting CWP， Fba1 and Pk confer in vivo protection in a specific way against each species of Candida. This makes them promising candidates for developing specific vaccines against these pathogens.
